By Raffaele Pereno – PhD, MBA
Basel, Switzerland – The Advanced Therapies Congress is Europe’s preeminent event dedicated to cell and gene therapy. As the largest conference and exhibition of its kind, it convenes over 3,300 senior executives and global stakeholders at ExCeL London for two days of strategic dialogue, knowledge exchange, and industry advancement.
Now in its 20th year, the Advanced Therapies Congress has continuously evolved into the leading global forum for the cell and gene therapy sector — hosting hundreds of distinguished speakers, thousands of attendees, and extensive networking opportunities. Its enduring mission is to unite advanced therapies leaders from around the world, provide critical insight, and promote collaboration to accelerate the development and commercialisation of next-generation medicines. The ultimate goal: to bring transformative therapies to market and improve patient outcomes worldwide.
This distinguished forum is designed for leaders of innovative ATMP companies and senior decision-makers who are shaping the future of advanced therapies through emerging technologies, regulatory strategy, and commercial innovation.
The congress features insights from more than 300 expert speakers and showcases 75 pioneering start-ups, representing the full spectrum of the advanced therapies ecosystem — including biotechnology and pharmaceutical firms, academic researchers, clinicians, health technology assessors, payers, and regulators.
With 10 focused content tracks, the agenda comprehensively addresses critical topics such as manufacturing, supply chain and logistics, pricing and market access, as well as the latest developments in cell therapy, gene therapy, gene-modified cell therapy, and immunotherapy.
The Advanced Therapies Congress offers a unique platform for global stakeholders to engage in high-level discussions, foster strategic partnerships, and stay at the forefront of innovation in this dynamic and rapidly advancing field.
Key Areas of Focus
- Evidence, Pricing & Access
- Gene Modified Cell Therapy
- Cell Therapy
- Gene Therapy
- Cell Therapy Manufacturing
- Viral Vector Manufacturing
- Supply Chain & Logistics
- Innovation Showcase
For further details about the Congress, including registration, please click here.
Congress at a glance
Venue: ExCeL London – Royal Victoria Dock, 1 Western Gateway, London E16 1XL (UK)
When: 17-18 March 2026
Contacts
To Sponsor or Exhibit
Ashlea Foster
[email protected]
+44 208 164 3032
To Speak
Chris Shanks
[email protected]
+44 207 092 1150